首页> 外文期刊>Injection Molding >Asthma sufferers benefit from antistat compound
【24h】

Asthma sufferers benefit from antistat compound

机译:哮喘患者受益于抗静电化合物

获取原文
获取原文并翻译 | 示例
       

摘要

A charge-neutral ABS compound from RTP Co. (Winona, MN; www.rtpcompany.com) ensures asthma patients get exactly the right dose of medication by eliminating static buildup that might result in the dosing device attracting and holding residual amounts. This is especially critical when used with a new class of inhalers that have replaced chlorofluoro-carbon (CFC) propellants with hydrofluoroalkane (HFA).
机译:来自RTP Co.(Winona,MN; www.rtpcompany.com)的电荷中性ABS化合物通过消除可能导致配量装置吸引并保持残留量的静态积聚,确保哮喘患者获得正确剂量的药物。当与一类新的吸入器一起使用时,这一点尤其重要,该吸入器已用氢氟烷烃(HFA)代替了氯氟烃(CFC)推进剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号